We focused on two distinct molecular subtypes with different risk profiles: ETV6::RUNX1+ (lower risk) and TCF3::PBX1+ (higher risk) childhood B-ALL. This evidence concerns the gene PBX1 and precursor B-cell acute lymphoblastic leukemia.